The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Muratov R.M.

Bakoulev National Medical Research Center for Cardiovascular Surgery

Sorkomov M.N.

Bakulev National Medical Research Center for Cardiovascular Surgery

Babenko S.I.

Bakoulev National Medical Research Center for Cardiovascular Surgery

Serov R.A.

Bakulev National Medical Research Center for Cardiovascular Surgery

Zharikova A.E.

Bakulev National Medical Research Center for Cardiovascular Surgery

Terekhov M.I.

Bakulev National Medical Research Center for Cardiovascular Surgery

Early postoperative results of cardiac surgery in patients with previous radiotherapy for Hodgkin’s lymphoma

Authors:

Muratov R.M., Sorkomov M.N., Babenko S.I., Serov R.A., Zharikova A.E., Terekhov M.I.

More about the authors

Read: 1003 times


To cite this article:

Muratov RM, Sorkomov MN, Babenko SI, Serov RA, Zharikova AE, Terekhov MI. Early postoperative results of cardiac surgery in patients with previous radiotherapy for Hodgkin’s lymphoma. Russian Journal of Cardiology and Cardiovascular Surgery. 2022;15(1):32‑39. (In Russ.)
https://doi.org/10.17116/kardio20221501132

Recommended articles:

References:

  1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:6:394-424.  https://doi.org/10.3322/caac.21492
  2. Shanbhag S, Ambinder RF. Hodgkin lymphoma: A review and update on recent progress CA. Cancer J Clin. 2018;68:116‐132.  https://doi.org/10.3322/caac.21438
  3. Jacobs EM, Peters FC, Luce JK, Zippin C, Wood DA. Mechlorethamine HCl and cyclophosphamide in the treatment of Hodgkin’s disease and the lymphomas. JAMA. 1968;203:392‐398. 
  4. Howlader N, Noone AM, Krapcho M, et al, eds. SEER Cancer Statistics Review, 1975—2014. Bethesda, MD: National Cancer Institute; 2017. seer.cancer.gov/csr/1975_2014/
  5. https://seer.cancer.gov/statfacts/html/hodg.html
  6. Cutter DJ, Schaapveld M, Darby SC, et al. Risk of valvular heart disease after treatment for Hodgkin lymphoma. J Natl Cancer Inst. 2015;107:4:djv008. https://doi.org/10.1093/jnci/djv008
  7. Carbone PP, Kaplan HS, Musshoff K, et al. Report of the Committee on Hodgkin’s disease staging classification. Cancer Res. 1971;31:1860-1861.
  8. Gujral DM, Shah BN, Chahal NS, et al. Clinical features of radiation-induced carotid atherosclerosis. Clin Oncol (R Coll Radiol). 2014;26:94-102. 
  9. Kaplan HS, Rosenberg SA. Extended-field radical radiotherapy in advanced Hodgkin’s disease: short-term results of 2 randomized clinical trials. Cancer Res. 1966;26:6:1268-1276.
  10. Aleman BMP, Van Den Belt-Dusebout AW, Klokman WJ, Van’t Veer MB, Bartelink H, Van Leeuwen FE. Long-term cause-specific mortality of patients treated for Hodgkin’s disease. Journal of Clinical Oncology. 2003;21:18:3431-3439.
  11. Cosset JM, Henry-Amar M, Meerwaldt JH, et al. Long-term toxicity of early stages of Hodgkin’s disease therapy: the EORTC experience-EORTC Lymphoma Cooperative Group. Annals of Oncology. 1991;2:2:77-82. 
  12. Henry-Amar M, Hayat M, Meerwaldt JH, et al. Causes of death after therapy for early stage Hodgkin’s disease entered on EORTC protocols. International Journal of Radiation Oncology Biology Physics. 1990;19:5:1155-1157.
  13. Ng AK, Bernardo MP, Weller E, et al. Long-term survival and competing causes of death in patients with early-stage Hodgkin’s disease treated at age 50 or younger. Journal of Clinical Oncology. 2002;20:8:2101-2108.
  14. Van Leeuwen FE, Klokman WJ, Van’t Veer MB, et al. Long-term risk of second malignancy in survivors of Hodgkin’s disease treated during adolescence or young adulthood. Journal of Clinical Oncology. 2000;18:3:487-497. 
  15. Sieber M, Engert A, Diehl V. Treatment of Hodgkin’s disease: results and current concepts of the German Hodgkin’s Lymphoma Study Group. Annals of Oncology. 2000;11:1:81-85. 
  16. O’Brien MM, Donaldson SS, Balise RR, et al. Second malignant neoplasms in survivors of pediatric Hodgkin’s lymphoma treated with low-dose radiation and chemotherapy. Journal of Clinical Oncology. 2010;28:7:1232-1239.
  17. Mulrooney DA, Yeazel MW, Kawashima T, et al. Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort. BMJ. 2009;339:b4606. https://doi.org/10.1136/bmj.b4606
  18. Wu W, Masri A, Popovic ZB, Smedira NG, Lytle B, Marwick TH, et al. Long-term survival of patients with radiation heart disease undergoing cardiac surgery: a cohort study. Circulation. 2013;127:1476-1485. https://doi.org/10.1161/CIRCULATIONAHA.113.001435
  19. Chang AS, Smedira NG, Chang CL, Benavides MM, Myhre U, Feng J, et al. Cardiac surgery after mediastinal radiation: extent of exposure influences outcome. J Thorac Cardiovasc Surg. 2007;133:404-413.  https://doi.org/10.1016/j.jtcvs.2006.09.041
  20. Desai MY, Karunakaravel K, Wu W, Agarwal S, Smedira NG, Lytle BW, Griffin BP. Pulmonary fibrosis on multidetector computed tomography and mortality in patients with radiation-associated cardiac disease undergoing cardiac surgery. J Thorac Cardiovasc Surg. 2014;148:475-481.  https://doi.org/10.1016/j.jtcvs.2013.08.087
  21. Fajardo LF. The pathology of ionizing radiation as defined by morphologic patterns. Keynote lecture, 5th Nordic Conference on Radiation Oncology, Bergen, Norway. Acta Oncologica. 2005;44:13-22.  https://doi.org/10.1080/02841860510007440
  22. Brown ML, Schaff HV, Sundt TM, et al. Conduit choice for coronary artery bypass grafting after mediastinal radiation. J Thorac Cardiovasc Surg. 2008;136:5:1167-1171. https://doi.org/10.1016/j.jtcvs.2008.07.005
  23. Veinot JP, Edwards WD. Pathology of radiation-induced heart disease: a surgical and autopsy study of 27 cases. Human Pathology. 1996;27:8:766-773.  https://doi.org/10.1016/s0046-8177(96)90447-5
  24. Brosius FC, Waller BF, Roberts WC. Radiation heart disease. Analysis of 16 young (aged 15 to 33 years) necropsy patients who received over 3,500 rads to the heart. American Journal of Medicine. 1981;70:3:519-530.  https://doi.org/10.1016/0002-9343(81)90574-x
  25. Liu LK, Ouyang W, Zhao X, Su SF, Yang Y, Ding WJ, et al. Pathogenesis and prevention of radiation-induced myocardial fibrosis. Asian Pac J Cancer Prev. 2017;18:3:583-587.  https://doi.org/10.22034/APJCP.2017.18.3.583
  26. Armstrong GT, Oeffinger KC, Chen Y, et al. Modifiable risk factors and major cardiac events among adult survivors of childhood cancer. J Clin Oncol. 2013;31:3673-3680.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.